Hamilton Wealth’s GSK GSK Stock Holding History

Hamilton Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-65,189	Closed	-$3.6M	–	130
2026 Q1	$3.6M	Buy	65,189 +8,584	+15%	+$465K	0.7%	34
2025 Q4	$2.78M	Buy	+56,605	New	+$2.64M	0.53%	38
2025 Q1	–	Sell	-7,350	Closed	-$249K	–	115
2024 Q4	$249K	Buy	+7,350	New	+$265K	0.06%	84
2024 Q2	–	Sell	-5,023	Closed	-$215K	–	112
2024 Q1	$215K	Buy	+5,023	New	+$207K	0.07%	93
2022 Q4	–	Sell	-89,288	Closed	-$2.63M	–	95
2022 Q3	$2.63M	Buy	+89,288	New	+$3.38M	1.11%	25
2020 Q1	–	Sell	-65,543	Closed	-$3.85M	–	38
2019 Q4	$3.85M	Buy	65,543 +768	+1%	+$42.7K	2.6%	16
2019 Q3	$3.46M	Buy	64,775 +1,381	+2%	+$71K	2.46%	17
2019 Q2	$3.17M	Buy	63,394 +6,660	+12%	+$334K	2.32%	15
2019 Q1	$2.96M	Buy	56,734 +35,772	+171%	+$1.79M	2.35%	15
2018 Q4	$1M	Buy	+20,962	New	+$1.03M	0.98%	36

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Hamilton Wealth's GSK Position: Q2 2026 in Review

Hamilton Wealth sold out of GSK (GSK) in Q2 2026, closing a stake of 65,189 shares — an estimated $3.6M sold.

Hamilton Wealth first reported a position in GSK in Q4 2018 and held it in 10 quarters. The position peaked at $3.85M in Q4 2019. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Hamilton Wealth reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
Hamilton Wealth sold 65,189 GSK shares in Q2 2026, an estimated $3.6M.
Hamilton Wealth first reported a position in GSK in Q4 2018 and held it in 10 quarters.
Hamilton Wealth's GSK position peaked at $3.85M in Q4 2019.
1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Hamilton Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.